NVOS (Novo Integrated Sciences) Debt-to-Asset : 0.13 (As of May. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NVOS Novo Integrated Sciences Inc NVOS
12 GF Score
Price $0.00
View Full Analysis

What is Novo Integrated Sciences Debt-to-Asset?

Novo Integrated Sciences NVOS -77.14% 12 Debt-to-Asset is 0.13 as of May. 2024. GuruFocus rates NVOS with a GF Score™ of 12/100.

Novo Integrated Sciences's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2024 was $2.90 Mil. Novo Integrated Sciences's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2024 was $1.60 Mil. Novo Integrated Sciences's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in May. 2024 was $35.33 Mil. Novo Integrated Sciences's debt to asset for the quarter that ended in May. 2024 was 0.13.

Novo Integrated Sciences  (OTCPK:NVOS) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Novo Integrated Sciences Debt-to-Asset Related Terms

Novo Integrated Sciences Debt-to-Asset Historical Data

* Premium members only.

The historical data trend for Novo Integrated Sciences's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novo Integrated Sciences Debt-to-Asset Chart

Novo Integrated Sciences Annual Data
Trend Dec14 Dec15 Dec16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.13 0.12 0.22 0.32 0.13

Novo Integrated Sciences Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.13 0.13 0.13 0.15 0.13

NVOS vs BACK, NHLG, FCHS: Debt-to-Asset Comparison

For the Medical Care Facilities subindustry, Novo Integrated Sciences's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Novo Integrated Sciences Debt-to-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Novo Integrated Sciences's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Novo Integrated Sciences's Debt-to-Asset falls into.


NVOS
12GF Score
Novo Integrated Sciences Inc NVOS
Debt-to-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Novo Integrated Sciences Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Novo Integrated Sciences's Debt-to-Asset for the fiscal year that ended in Aug. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.713 + 1.759) / 35.563
=0.13

Novo Integrated Sciences's Debt-to-Asset for the quarter that ended in May. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(2.904 + 1.598) / 35.327
=0.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Asset →
What does a Debt-to-Asset of 0.13 mean?
Novo Integrated Sciences (NVOS) has a Debt-to-Asset of 0.13 as of May. 2024. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Novo Integrated Sciences and its competitors.
Is Novo Integrated Sciences' Debt-to-Asset too high?
Novo Integrated Sciences' current Debt-to-Asset is 0.13. Overall, Novo Integrated Sciences has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Novo Integrated Sciences' Debt-to-Asset compare to BACK and NHLG?
Novo Integrated Sciences' Debt-to-Asset of 0.13 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Asset for a Healthcare Providers & Services company?
A good Debt-to-Asset depends on the Healthcare Providers & Services industry context. However, Debt-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Asset mean?
A high Debt-to-Asset can signal that a stock is expensive relative to its fundamentals. Debt-to-asset ratio represents the ratio of total debt to total assets. View historical data on Novo Integrated Sciences and its competitors. Novo Integrated Sciences's current Debt-to-Asset is 0.13. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Novo Integrated Sciences stock overvalued right now?
Novo Integrated Sciences (NVOS) has a current Debt-to-Asset of 0.13. The current Debt-to-Asset is 0.13. Novo Integrated Sciences' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Asset calculated?
Debt-to-Asset is calculated from a company's financial statements. For Novo Integrated Sciences (NVOS), the current Debt-to-Asset is 0.13 as of May. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Novo Integrated Sciences Business Description

Address 11120 NE 2nd Street, Suite 100, Bellevue, WA, USA, 98004
Novo Integrated Sciences Inc is a medical care company. It provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, massage therapy, acupuncture, neurological functions, kinesiology, and others. It has two reportable segments: healthcare services and product sales. Healthcare services generate the majority of revenue.
12GF Score

Get the complete analysis for NVOS

Debt-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price